| Genetic, transcriptional and post-translational regulation of the programmed death protein ligand 1 in cancer: biology and clinical correlations I Zerdes, A Matikas, J Bergh, GZ Rassidakis, T Foukakis Oncogene 37 (34), 4639-4661, 2018 | 255 | 2018 |
| Prognostic implications of PD-L1 expression in breast cancer: systematic review and meta-analysis of immunohistochemistry and pooled analysis of transcriptomic data A Matikas, I Zerdes, J Lövrot, F Richard, C Sotiriou, J Bergh, A Valachis, ... Clinical Cancer Research 25 (18), 5717-5726, 2019 | 92 | 2019 |
| STAT3 Activity Promotes Programmed-Death Ligand 1 Expression and Suppresses Immune Responses in Breast Cancer I Zerdes, M Wallerius, EG Sifakis, T Wallmann, S Betts, M Bartish, ... Cancers 11 (10), 1479, 2019 | 74 | 2019 |
| Non-epithelial Ovarian Cancer: Elucidating Uncommon Gynaecological Malignancies S Boussios, G Zarkavelis, E Seraj, I Zerdes, K Tatsi, G Pentheroudakis Anticancer research 36 (10), 5031-5042, 2016 | 74 | 2016 |
| Beyond PD-1/PD-L1 Inhibition: What the Future Holds for Breast Cancer Immunotherapy S Chrétien, I Zerdes, J Bergh, A Matikas, T Foukakis Cancers 11 (5), 628, 2019 | 63 | 2019 |
| Discordance of PD-L1 status between primary and metastatic breast cancer: A systematic review and meta-analysis C Boman, I Zerdes, K Mårtensson, J Bergh, T Foukakis, A Valachis, ... Cancer Treatment Reviews 99, 102257, 2021 | 55 | 2021 |
| Immune gene expression and response to chemotherapy in advanced breast cancer T Foukakis, J Lövrot, A Matikas, I Zerdes, J Lorent, N Tobin, C Suzuki, ... British journal of cancer 118 (4), 480-488, 2018 | 43 | 2018 |
| SETD2 mutation in renal clear cell carcinoma suppress autophagy via regulation of ATG12 P González-Rodríguez, P Engskog-Vlachos, H Zhang, AN Murgoci, ... Cell Death & Disease 11 (1), 1-15, 2020 | 38 | 2020 |
| Neoadjuvant Trastuzumab, Pertuzumab, and Docetaxel vs Trastuzumab Emtansine in Patients With ERBB2-Positive Breast Cancer: A Phase 2 Randomized Clinical Trial T Hatschek, T Foukakis, J Bjöhle, T Lekberg, H Fredholm, E Elinder, ... JAMA oncology 7 (9), 1360-1367, 2021 | 36 | 2021 |
| The role of statins in prevention of preeclampsia: a promise for the future? V Katsi, G Georgountzos, MS Kallistratos, I Zerdes, T Makris, AJ Manolis, ... Frontiers in pharmacology 8, 247, 2017 | 35 | 2017 |
| Extranodal diffuse large B-cell lymphomas: A retrospective case series and review of the literature S Boussios, I Zerdes, A Vassou, E Bareta, E Seraj, A Papoudou-Bai, ... Hematology reports 10 (1), 2018 | 26 | 2018 |
| How can we effectively address the paraneoplastic dermatomyositis: Diagnosis, risk factors and treatment options I Zerdes, M Tolia, M Nikolaou, N Tsoukalas, L Velentza, J Hajiioannou, ... J BUON 22 (4), 1073-80, 2017 | 25 | 2017 |
| Sense of Coherence and Defense Style Predict Sleep Difficulties in Early Non-metastatic Colorectal Cancer T Hyphantis, P Goulia, I Zerdes, S Solomou, E Andreoulakis, AF Carvalho, ... Digestive diseases and sciences 61 (1), 273-282, 2016 | 23 | 2016 |
| Programmed death‐ligand 1 gene expression is a prognostic marker in early breast cancer and provides additional prognostic value to 21‐gene and 70‐gene signatures in estrogen … I Zerdes, EG Sifakis, A Matikas, S Chrétien, NP Tobin, J Hartman, ... Molecular oncology 14 (5), 951-963, 2020 | 22 | 2020 |
| Pancreatic resection for renal cell carcinoma metastasis: An exceptionally rare coexistence S Boussios, I Zerdes, O Batsi, VP Papakostas, E Seraj, G Pentheroudakis, ... International journal of surgery case reports 27, 198-201, 2016 | 22 | 2016 |
| Anti-VEGF anticancer drugs: mind the hypertension V Katsi, Z Ioannis, M Stavroula, M Thomas, N Petros, T Dimitris, K Ioannis Recent Patents on Cardiovascular Drug Discovery 9 (2), 63-72, 2014 | 18 | 2014 |
| Systemic therapy of metastatic renal cell carcinoma: Review of the current literature I Zerdes, M Tolia, N Tsoukalas, M Mitsis, D Kardamakis, ... Urologia Journal 86 (1), 3-8, 2019 | 17 | 2019 |
| Survival outcomes, digital TILs and on-treatment PET/CT during neoadjuvant therapy for HER2-positive breast cancer: results from the randomized PREDIX HER2 trial A Matikas, H Johansson, P Grybäck, J Bjöhle, B Acs, C Boyaci, T Lekberg, ... Clinical Cancer Research, 2022 | 15 | 2022 |
| PD-1 protein and gene expression as prognostic factors in early breast cancer A Matikas, I Zerdes, J Lövrot, E Sifakis, F Richard, C Sotiriou, ... ESMO Open 5 (6), e001032, 2020 | 14 | 2020 |
| Plasmablastic Lymphoma with Coexistence of Chronic Lymphocytic Leukemia in an Immunocompetent Patient: A Case Report and Mini-Review E Hatzimichael, K Papathanasiou, I Zerdes, S Flindris, A Papoudou-Bai, ... Case reports in hematology 2017, 2017 | 14 | 2017 |
